The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Methylphenidate for Cancer-Related Fatigue
Official Title: Methylphenidate for Cancer-Related Fatigue: A Pilot N-of-1 Study
Study ID: NCT01164956
Brief Summary: The overall aim of this pilot study is to conduct a combined N-of-1 trial (N-1-T) of MPH (methylphenidate) for amelioration of fatigue in children with cancer, and to evaluate the N-1-T design both for individual clinical decision making and for clinical trials in symptom management in pediatric oncology patients. Because no one knows which of the study options are best, participants will receive liquid MPH on some days and a placebo on other days. We will compare how the participant feels on MPH days with how they feel on placebo days to determine whether MPH makes a difference.
Detailed Description: I. To assess the N-1-T as a study design to evaluate a symptom-directed intervention in children with cancer Primary objective -To evaluate the feasibility of conducting an N-1-T to evaluate MPH for cancer-related fatigue in children as a group Secondary objectives * To evaluate the ability of the N-1-T to assess efficacy of MPH for an individual subject statistically and clinically definite answer (regarding the ability of MPH to reduce fatigue) * To explore subject/family and oncologist perspectives on N1T participation * To examine in a preliminary fashion whether there are patient, family, disease or study-related factors that are associated with attrition to help guide future large-scale N1Ts II. To evaluate MPH for treatment of cancer-related fatigue and related symptoms in children Primary objective -To evaluate the effect of MPH on cancer-related fatigue in children based on various assessments including pedsFACIT-F and a unidimensional single-item Likert scale for measuring fatigue Secondary objective -To assess the side effect profile of MPH for fatigue in children with cancer III. To evaluate fatigue assessment tools Primary objective -To evaluate correlation between fatigue scores
Minimum Age: 7 Years
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Boston Children's Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Name: Christina Ullrich, MD, MPH
Affiliation: Dana-Farber Cancer Institute/Children's Hospital Boston
Role: PRINCIPAL_INVESTIGATOR